| HOME >> BIOLOGY >> TECHNOLOGY |
Long-term liabilities, less current portion:
Unsecured loans payable 1,510,078 1,472,717
Bank notes payable - 1,351
Long-term convertible notes payable 2,171,401 2,365,962
Discount relating to warrants issued
with long-term convertible notes (1,066,342) (1,371,446)
Total long-term liabilities 2,615,137 2,468,584
Minority interest in a subsidiary 95,292 103,362
Shareholders' equity (deficiency)
Common stock - $0.001 par value
Authorized 200,000,000 shares at
June 30, 2007 and December 31, 2006
respectively. Issued and outstanding
75,120,710 and 70,149,556 shares at
June 30, 2007 and December 31, 2006,
respectively 75,121 70,150
Preferred stock - $0.001 par value
Authorized 20,000,000 shares, nil
shares issued and outstanding
at June 30, 2007 and December
31, 2006, respectively - -
Additional paid-in capital 8,714,848 8,311,975
Stock-based compensation reserve (389,342) (523,468)
Deficit Accumulated (9,712,807) (7,766,654)
Accumulated other comprehensive income 3,632 1,166
Total shareholders' equity (deficiency) (1,308,548) 93,169
Total liabilities and stockholders'
equity $3,627,740 $4,518,185
SOURCE Kiwa Bio-Tech Products Group Corporation![]() Copyright©2007 PR Newswire. |